July 28, 2021
Takeda Pharmaceutical and PeptiDream said on July 27 that they will expand their existing peptide-drug conjugate (PDC) collaboration into the neurodegenerative disease arena. In December 2020, the two partners sealed a collaborative research and exclusive license pact for the development...read more